Ashok K. Vaid

1.6k total citations · 1 hit paper
54 papers, 1.1k citations indexed

About

Ashok K. Vaid is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ashok K. Vaid has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Ashok K. Vaid's work include Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (7 papers) and Cancer Genomics and Diagnostics (6 papers). Ashok K. Vaid is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (7 papers) and Cancer Genomics and Diagnostics (6 papers). Ashok K. Vaid collaborates with scholars based in India, United States and United Kingdom. Ashok K. Vaid's co-authors include P. P. Bapsy, A. Feyereislova, Michaela Lehle, Michaela K. Jahn, Alison Jones, Bella Kaufman, Michael Clemens, Sergei Tjulandin, John R. Mackey and Cédric Révil and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ashok K. Vaid

51 papers receiving 1.0k citations

Hit Papers

Trastuzumab Plus Anastrozole Versus Anastrozole Alone for... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers

Ashok K. Vaid
Ashok K. Vaid
Citations per year, relative to Ashok K. Vaid Ashok K. Vaid (= 1×) peers Elisa Zanardi

Countries citing papers authored by Ashok K. Vaid

Since Specialization
Citations

This map shows the geographic impact of Ashok K. Vaid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashok K. Vaid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashok K. Vaid more than expected).

Fields of papers citing papers by Ashok K. Vaid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashok K. Vaid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashok K. Vaid. The network helps show where Ashok K. Vaid may publish in the future.

Co-authorship network of co-authors of Ashok K. Vaid

This figure shows the co-authorship network connecting the top 25 collaborators of Ashok K. Vaid. A scholar is included among the top collaborators of Ashok K. Vaid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashok K. Vaid. Ashok K. Vaid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaid, Ashok K., Olivia Pagani, Chirag Desai, et al.. (2024). Optimizing Premenopausal Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer Management in India: Insights From Expert Consensus. Cureus. 16(12). e76392–e76392. 1 indexed citations
2.
Vaid, Ashok K., et al.. (2023). Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective. Human Vaccines & Immunotherapeutics. 19(2). 2224186–2224186. 4 indexed citations
3.
Crook, Timothy, Robert Leonard, Kefah Mokbel, et al.. (2022). Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells. Cancers. 14(14). 3341–3341. 24 indexed citations
4.
Bhartiya, Deepa, et al.. (2021). Quest for Pan-Cancer Diagnosis/Prognosis Ends with HrC Test Measuring Oct4A in Peripheral Blood. Stem Cell Reviews and Reports. 17(5). 1827–1839. 11 indexed citations
5.
Yoo, Changwon, Quentin Felty, Juan P. Liuzzi, et al.. (2020). Sensitivity to differential NRF1 gene signatures contributes to breast cancer disparities. Journal of Cancer Research and Clinical Oncology. 146(11). 2777–2815. 15 indexed citations
6.
Vaid, Ashok K., Sudeep Gupta, Dinesh Doval, et al.. (2020). Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective. Frontiers in Oncology. 10. 400–400. 10 indexed citations
7.
Vaid, Ashok K., Dheeraj Gautam, Jyoti Wadhwa, et al.. (2020). Clinical Characteristics and Outcome Trends of Adjuvant Anthracycline and Taxane Regimen for Early Stage Breast Cancer. World Journal of Oncology. 11(3). 106–111. 4 indexed citations
8.
Prabhash, Kumar, Suresh H. Advani, Ullas Batra, et al.. (2019). Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing. Advances in Therapy. 36(4). 766–785. 18 indexed citations
9.
Aggarwal, Geet, et al.. (2019). Successful treatment of Sezary syndrome with extracorporeal photopheresis – The first attempt in India. Asian Journal of Transfusion Science. 13(1). 66–66.
11.
Hsu, Li Yang, Dong‐Gun Lee, Dinesh Bhurani, et al.. (2015). Epidemiology of invasive fungal diseases among patients with haematological disorders in the Asia-Pacific: a prospective observational study. Clinical Microbiology and Infection. 21(6). 594.e7–594.e11. 36 indexed citations
12.
Vaid, Ashok K., et al.. (2015). Mediastinal germ cell tumour causing superior vena cava tumour thrombosis. BMJ Case Reports. 2015. bcr2014208356–bcr2014208356. 5 indexed citations
14.
Batra, Sandeep, Ashok K. Vaid, Rahul Bhargava, & Amanjeet Singh. (2013). Malignancy knows no boundaries. BMJ Case Reports. 2013. bcr2013010383–bcr2013010383. 3 indexed citations
15.
Vaid, Ashok K., et al.. (2011). Cystalline inclusions in plasma cells. Indian Journal of Pathology and Microbiology. 54(4). 836–836. 2 indexed citations
16.
Vaid, Ashok K.. (2011). Nilotinib as first-line therapy for chronic myeloid leukemia. Indian Journal of Cancer. 48(4). 438–438. 3 indexed citations
17.
Doval, D.C., et al.. (2007). Report of a Case of Pericardial Mesothelioma with Liver Metastases Responding Well to Pemetrexed and Platinum-Based Chemotherapy. Journal of Thoracic Oncology. 2(8). 780–781. 11 indexed citations
18.
Parikh, Purvish M., Ashok K. Vaid, Suresh H. Advani, et al.. (2007). C1-05: Oral talactoferrin extends survival in patients with refractory NSCLC in a randomized, placebo-controlled, phase 2 trial. Journal of Thoracic Oncology. 2(8). S360–S360. 2 indexed citations
19.
Doval, Dinesh Chandra, Komal Bhatia, Ashok K. Vaid, et al.. (2006). Spinal cord compression secondary to bone metastases from hepatocellular carcinoma.. Europe PMC (PubMed Central). 12(32). 5247–52. 24 indexed citations
20.
Doval, Dinesh Chandra, et al.. (2005). Bone metastases from primary hepatocellular carcinoma simulating multiple myeloma.. PubMed. 4(2). 308–10. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026